|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2009-5-8
|
|
pubmed:abstractText |
We investigated a method for assessing early improvement and predictive factors of early and late outcomes in patients receiving thrombolytic therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1878-5883
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
281
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
69-73
|
|
pubmed:meshHeading |
pubmed-meshheading:19304298-Aged,
pubmed-meshheading:19304298-Atrial Fibrillation,
pubmed-meshheading:19304298-Carotid Artery Diseases,
pubmed-meshheading:19304298-Female,
pubmed-meshheading:19304298-Fibrinolytic Agents,
pubmed-meshheading:19304298-Humans,
pubmed-meshheading:19304298-Injections, Intra-Arterial,
pubmed-meshheading:19304298-Injections, Intravenous,
pubmed-meshheading:19304298-Male,
pubmed-meshheading:19304298-Middle Aged,
pubmed-meshheading:19304298-ROC Curve,
pubmed-meshheading:19304298-Severity of Illness Index,
pubmed-meshheading:19304298-Smoking,
pubmed-meshheading:19304298-Stroke,
pubmed-meshheading:19304298-Thrombolytic Therapy,
pubmed-meshheading:19304298-Tissue Plasminogen Activator,
pubmed-meshheading:19304298-Treatment Outcome,
pubmed-meshheading:19304298-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
|
|
pubmed:affiliation |
Department of Neurology and National Core Research Center for Nanomedical Technology, Yonsei University College of Medicine, Seoul, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
